[On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].
D000227:Adenine Nucleotides / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D003401:Creatine / Q000378:metabolism; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D011299:Prenylamine / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*
D000227:Adenine Nucleotides; D000889:Anti-Arrhythmia Agents; D013565:Sympatholytics; D013566:Sympathomimetics; D014665:Vasodilator Agents; D000255:Adenosine Triphosphate; D011299:Prenylamine; D003401:Creatine
Zum Wirkungsmechanismus neuartiger Koronardilatatoren mit gleichzeitig Sauerstoff-einsparenden Myokard-Effekten, Prenylamin und Iproveratril. 1.